Due to the fact folks who have the APOE e4 gene variant appear to have a higher threat of great troubles, the FDA endorses staying tested for the gene variant before starting treatment with lecanemab or donanemab. The extension examine also evaluated CLARITY AD members who had a delayed start https://josefav753rak2.wikinarration.com/user